Topic: Cardiology

JANUARY 20, 2021 BY SEAN WHOOLEY  Abbott (NYSE:ABT) announced today that CMS revised its coverage for TMVR, opening […]

Omar Ford | Jan 21, 2021 Boston Scientific is heading back to the M&A trail after […]

FDA has granted breakthrough status to two medical devices aimed at Alzheimer’s disease patients in […]

Dive Brief: CMS expanded coverage of mitral valve transcatheter edge-to-edge repair procedures, previously known as transcatheter […]

iRhythm Technologies (NSDQ:IRTC) announced that president & CEO Kevin King will retire; longtime Medtronic executive Mike […]

Ajax Health-backed Ablacon announced that it closed a Series B financing round worth $30 million with a […]

Edward Lifesciences made a huge advancement in its move to get its Harpoon Mitral Valve […]

4C Medical Technologies announced that it completed an over-subscribed convertible note financing worth $10 million in […]

Startup CoraVie Medical aims to give patients and their physicians better control over hypertension with […]

Edwards Lifesciences (NYSE:EW) today announced that Health Canada has approved the expanded use of the company’s […]

Abiomed (NSDQ:ABMD) announced that it treated the first two patients with its Abiomed Breethe OXY-1 compact […]

Medtronic Canada (NYSE:MDT) announced that it received a Health Canada license for its Micra AV pacemaker […]

2020 has seen significant movement in the mitral valves from many of the smaller companies […]

The company ends its 2020 with a high-profile deal. Philips started the year with a […]

Biotronik today announced FDA clearance of its Vital Data Sensor, designed to identify body temperature increases […]

Cardiac imaging technology developer Genetesis announced today that its flagship product received FDA breakthrough device designation. Mason, […]

BioCardia (OTC:BCDA) announced that it entered into a securities purchase agreement for the sale of shares […]

iRhythm Technologies (NSDQ:IRTC) announced that president & CEO Kevin King will retire; longtime Medtronic executive Mike […]

ReCor Medical this week announced that its Paradise Ultrasound Renal Denervation System won FDA breakthrough device […]

Edwards Lifesciences (NYSE:EW) is projecting significant growth for 2021, particularly in its transcatheter aortic valve replacement […]

Zimmer Biomet today said it completed the acquisition of A&E Medical for $150 million in […]

iRhythm Technologies (NSDQ:IRTC) announced that it received a recommendation for adoption from National Institute for Health […]

The Centers for Medicare & Medicaid Services (CMS) finalized policies that increase access to artificial […]

LivaNova (NSDQ:LIVN) announced today that it has agreed to sell its heart valve business to Gyrus […]

The award-winning next-generation MitraClip from Abbott (NYSE:ABT) reportedly performs as well as the previous version of the […]

Vectorious Medical Technologies today announced that the FDA has granted breakthrough device designation for the company’s […]

AI-based electrocardiogram (ECG) technology developer AliveCor announced that it received FDA clearance for its next-gen ECG algorithms. […]

Boston Scientific (NYSE:BSX) has reportedly confirmed job losses at its Galway, Ireland, location, following the retirement […]

Boston Scientific (NYSE:BSX) announced today that it has initiated a global, voluntary recall of its Lotus […]

Acutus Medical (NSDQ:AFIB) announced that it appointed Dr. Steven Mickelsen as its chief translational science officer. […]

The company, which makes a digital stethoscope and electrocardiogram, raised $65 million in series C […]

CVRx announced that it received the CMS inpatient new technology add-on payment (NTAP) for its Barostim […]

Abbott (NYSE:ABT) announced today that it received the 2020 Prix Galien USA Award for Best Medical […]

Dive Brief: FDA’s circulatory system devices panel Tuesday is examining a premarket approval application for […]

Livmor has won a nod from FDA for a physician-prescribed wearable that continuously monitors for […]

Abiomed (NSDQ:ABMD) today announced interim results of a study that found high-risk patients had better outcomes […]

The Xience Sierra is one of nine Xience everolimus-eluting cardiovascular stents. A pair of studies […]

Boston Scientific’s Acurate Neo failed to demonstrate non-inferiority when compared to Medtronic’s CoreValve Evolut transcatheter aortic […]

Dive Brief: Medtronic has initiated a head-to-head postmarket trial to compare its transcatheter aortic valve […]